Stocks
Xenetic Biosciences, Inc.XBIO
NASDAQHealthcareBiotechnology$2.00
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing next-generation biologic drugs for oncology and other serious diseases. Its proprietary platform technology, PolyXen, enables the creation of long-acting versions of therapeutic proteins and peptides. Investors track Xenetic for its pipeline of drug candidates and potential licensing deals.
52W Range: $1.85-$4.94
Congressional Interest in Xenetic Biosciences, Inc. (XBIO)
No congressional trades have been disclosed for Xenetic Biosciences, Inc. (XBIO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading XBIO?
No congressional trades found for this stock.